DENTSPLY SIRONA (NASDAQ:XRAY) Given New $20.00 Price Target at Robert W. Baird

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective decreased by Robert W. Baird from $22.00 to $20.00 in a research note published on Friday,Benzinga reports. Robert W. Baird currently has a neutral rating on the medical instruments supplier’s stock.

Other analysts have also issued reports about the stock. Leerink Partnrs lowered shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a report on Thursday, November 7th. Evercore ISI restated an “in-line” rating and issued a $20.00 price objective on shares of DENTSPLY SIRONA in a report on Tuesday, January 7th. Needham & Company LLC lowered their price objective on shares of DENTSPLY SIRONA from $25.00 to $23.00 and set a “buy” rating for the company in a report on Friday. UBS Group decreased their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating for the company in a research note on Tuesday, December 3rd. Finally, Jefferies Financial Group downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and decreased their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Eleven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. Based on data from MarketBeat, DENTSPLY SIRONA currently has an average rating of “Hold” and an average target price of $23.58.

DENTSPLY SIRONA Stock Performance

Shares of XRAY opened at $16.55 on Friday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA has a one year low of $16.21 and a one year high of $34.91. The company has a 50-day simple moving average of $18.88 and a two-hundred day simple moving average of $21.55. The firm has a market capitalization of $3.29 billion, a PE ratio of -8.00, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Stockholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.87%. The ex-dividend date is Friday, March 28th. DENTSPLY SIRONA’s payout ratio is currently -30.92%.

Institutional Investors Weigh In On DENTSPLY SIRONA

Several institutional investors have recently modified their holdings of the business. Pacer Advisors Inc. increased its holdings in DENTSPLY SIRONA by 15,105.1% in the 4th quarter. Pacer Advisors Inc. now owns 4,503,591 shares of the medical instruments supplier’s stock worth $85,478,000 after buying an additional 4,473,972 shares in the last quarter. Nuance Investments LLC increased its holdings in DENTSPLY SIRONA by 25.0% in the 4th quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier’s stock worth $257,103,000 after buying an additional 2,708,097 shares in the last quarter. Norges Bank bought a new stake in DENTSPLY SIRONA in the 4th quarter worth about $45,730,000. AQR Capital Management LLC increased its holdings in DENTSPLY SIRONA by 245.1% in the 4th quarter. AQR Capital Management LLC now owns 2,893,023 shares of the medical instruments supplier’s stock worth $54,389,000 after buying an additional 2,054,767 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD increased its holdings in DENTSPLY SIRONA by 18.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier’s stock worth $238,186,000 after buying an additional 1,975,404 shares in the last quarter. 95.70% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.